ClinConnect ClinConnect Logo
Search / Trial NCT06485960

Validation of the Experience Sampling Dietary Assessment Method

Launched by KU LEUVEN · Jun 26, 2024

Trial Information

Current as of August 23, 2025

Not yet recruiting

Keywords

Dietary Assessment Validation Experience Sampling Digital Health Digital Biomarkers Doubly Labeled Water Esm

ClinConnect Summary

This clinical trial is testing a new way to track what people eat, called the Experience Sampling Dietary Assessment Method (ESDAM). Researchers want to make sure this method is accurate and reliable by comparing it with other well-established ways of measuring diet. The goal is to see if ESDAM can be used effectively in research and healthcare settings to help understand people's eating habits.

To participate in this study, you need to be between the ages of 65 and 74, have a smartphone, and be comfortable using apps. You should also have a freezer at home and be able to understand Dutch. It's important that your weight has been stable (not changing by more than 5%) in the last three months, and you should not be trying to lose or gain weight during the study. If you are pregnant, breastfeeding, or on a special diet for medical reasons, you won’t be able to join. If you take part, you will help researchers develop a tool that could improve how dietary habits are measured in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed informed consent
  • Having a smartphone and being capable of using the smartphone and apps
  • Having a freezer at home
  • Sufficient knowledge of the Dutch language to understand and participate in the study
  • Having a stable body weight (body weight not changed by 5% last 3 months)
  • Not aiming to gain or lose weight during the study period
  • Exclusion Criteria:
  • Pregnant or lactating women
  • Not following a specific diet for medical reasons (i.e. coeliac disease)

About Ku Leuven

KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.

Locations

Patients applied

0 patients applied

Trial Officials

Christophe Matthys, PhD

Principal Investigator

KU Leuven/UZ Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported